XLAB Exascale Labs Holdings Inc.

Overview and Growth

In fiscal 2026, Exascale Labs Holdings Inc. recorded $14.82M of revenue, net loss of $12.16M, and an operating cash outflow of $2.75M. Revenue of $14.82M sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line expanded 111.3% from $7.02M in fiscal 2025, increasing the company’s operating scale. The company reported diluted EPS of -$8108.26, adding a shareholder-level measure to the absolute income figures considered below. Diluted shares averaged 1.50K; this is the reported share base over which the company’s diluted per-share earnings were spread. Compared with 1.50K diluted shares in fiscal 2025, the current 1.50K base was 0.0% higher. Total assets stood at $6.73M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Revenue equaled 2.2x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

After reported cost of revenue, the company retained $2.42M as gross profit before recognizing operating expenses and other items. Gross margin was 16.3%, so that share of each revenue unit remained after the cost of revenue reported for the period. The reported operating result was an operating loss of $4.80M, reflecting costs that exceeded gross profit. The operating loss equaled 32.4% of revenue, showing the scale of the operating deficit relative to sales. The company ended the period with a net loss of $12.16M, extending the operating result through all remaining items. Measured against revenue, the bottom-line deficit represented 82.1% after all recognized items. The company reported negative EBITDA of $4.79M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. The pretax result was a loss of $12.16M, establishing the deficit before tax effects. Pretax margin was -82.1%, reflecting a pre-tax loss equal to 82.1% of revenue. The loss-to-assets relationship was 180.8%, placing the bottom-line deficit against the company’s resource base. The net loss widened to $12.16M from $7.66M in fiscal 2025.

Liquidity and Capital Structure

Total assets were $6.73M, supported by $31.89M of liabilities and -$25.16M of shareholder equity. With total equity at -$25.16M, the company carried a negative book-capital position, increasing its reliance on liabilities and future earnings. Current assets were $6.52M against $31.89M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. The current ratio was 0.2x; current liabilities exceeded current assets, leaving a short-term liquidity deficit. The company held $2.69M in cash and equivalents, a narrower liquidity measure than total current assets. Cash and equivalents represented 8.4% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The equity-to-assets relationship was -374.0%, placing book capital against the total resource base. The liabilities-to-assets relationship was 474.0%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 40.0%, comparing reported cash and equivalents with the full positive asset balance. Compared with $7.32M in fiscal 2025, the current asset base moved 8.1% and finished lower. Cash and equivalents were 36.3% lower than fiscal 2025 cash of $4.23M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities used $2.75M of cash, resulting in an operating cash outflow for the year. The operating cash outflow widened to $2.75M from $1.01M in fiscal 2025.

Based on the annual report for the fiscal year ending Jun 30, 2026. Analysis generated Oct 21, 2026.